Variant report
| Variant | nsv933440 |
|---|---|
| Chromosome Location | chr7:103301959-103312307 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:17)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
(count:17 , 50 per page) page:
1
| No. | Distal block | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr7:103302157..103305081-chr7:103307428..103309222,2 | K562 | blood: | |
| 2 | chr7:103308135..103310700-chr7:103389205..103391721,2 | K562 | blood: | |
| 3 | chr7:103302444..103304759-chr7:103358804..103361595,2 | K562 | blood: | |
| 4 | chr7:103304565..103307754-chr7:103310017..103312490,3 | MCF-7 | breast: | |
| 5 | chr7:103298261..103300051-chr7:103303865..103306528,3 | K562 | blood: | |
| 6 | chr7:103297074..103301566-chr7:103303216..103306956,8 | K562 | blood: | |
| 7 | chr7:103302157..103305081-chr7:103307428..103309222,2 | K562 | blood: | |
| 8 | chr7:103299093..103302989-chr7:103306962..103309461,4 | K562 | blood: | |
| 9 | chr7:103254507..103256433-chr7:103303415..103304942,2 | K562 | blood: | |
| 10 | chr7:103304565..103307754-chr7:103310017..103312490,3 | MCF-7 | breast: | |
| 11 | chr7:103297764..103300699-chr7:103309943..103311774,3 | K562 | blood: | |
| 12 | chr7:103305325..103307446-chr7:103308405..103311533,3 | K562 | blood: | |
| 13 | chr7:103309641..103312329-chr7:103801017..103803175,2 | K562 | blood: | |
| 14 | chr7:103305325..103307446-chr7:103308405..103311533,3 | K562 | blood: | |
| 15 | chr7:103299093..103302989-chr7:103306962..103309461,4 | K562 | blood: | |
| 16 | chr7:103297558..103299544-chr7:103301065..103303822,2 | K562 | blood: | |
| 17 | chr7:103298022..103299710-chr7:103300574..103302831,2 | K562 | blood: |
| No data |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs369642019 | chr7:103301981-103301982 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs146986040 | chr7:103301985-103301986 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs543063078 | chr7:103302028-103302029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs560950128 | chr7:103302046-103302047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs11974290 | chr7:103302117-103302118 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 6 | rs549686385 | chr7:103302135-103302136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs187999683 | chr7:103302136-103302137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs536352540 | chr7:103302152-103302153 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs537221782 | chr7:103302173-103302174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs193057552 | chr7:103302174-103302175 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs150382591 | chr7:103302216-103302217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs138064329 | chr7:103302222-103302223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs535962778 | chr7:103302236-103302237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs185772816 | chr7:103302255-103302256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs569636210 | chr7:103302262-103302263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs11974325 | chr7:103302279-103302280 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 17 | rs573899043 | chr7:103302292-103302293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs78480421 | chr7:103302322-103302323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs371004537 | chr7:103302349-103302350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs578260220 | chr7:103302376-103302377 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs187392378 | chr7:103302540-103302541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs192180813 | chr7:103302563-103302564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs11975158 | chr7:103302629-103302630 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 24 | rs10242211 | chr7:103302665-103302666 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 25 | rs545909097 | chr7:103302749-103302750 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs561458753 | chr7:103302750-103302751 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs6950480 | chr7:103302791-103302792 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 28 | rs4377881 | chr7:103302817-103302818 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs149533452 | chr7:103302843-103302844 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs564694925 | chr7:103302844-103302845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs147204211 | chr7:103302851-103302852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs112017933 | chr7:103302874-103302875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs565350164 | chr7:103302888-103302889 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs529675257 | chr7:103302933-103302934 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs543720973 | chr7:103302941-103302942 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs373784014 | chr7:103302962-103302963 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs536738694 | chr7:103302985-103302986 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs561905522 | chr7:103302998-103302999 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs13238300 | chr7:103303067-103303068 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 40 | rs112276058 | chr7:103303068-103303069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs11414600 | chr7:103303073-103303074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs55654544 | chr7:103303092-103303093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs539364905 | chr7:103303128-103303129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs13238565 | chr7:103303130-103303131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs2382879 | chr7:103303136-103303137 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 46 | rs114399266 | chr7:103303206-103303207 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs13238689 | chr7:103303227-103303228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs559223664 | chr7:103303270-103303271 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs2382880 | chr7:103303355-103303356 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 50 | rs148513520 | chr7:103303359-103303360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Basal cell lymphoma | 17170743 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Seminomas | 18059402 | CNVD |
| Testicular cancer | 18059402 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Autism | 19415332 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Malaria | 21533027 | CNVD |
| Melanoma | 18172304 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| head and neck squamous cell carcinoma | 19289630 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Ewing''s sarcoma | 17952124 | CNVD |
| Autism | 22495311 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Non-small cell lung cancer | 21829676 | CNVD |
| Gastric cancer | 24379144 | CNVD |
| Glioblastoma multiforme | 17002787 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Lissencephaly | 21572526 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Squamous cell cancer | 21044232 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Low-grade fibromyxoid sarcoma | 0 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Burkitt''s lymphoma | 18698080 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Shwachman-Diamond syndrome | 22934832 | CNVD |
| Colorectal cancer | 19359472 | CNVD |
| Cutaneous malignant melanoma | 17690212 | CNVD |
| Leukemia | 17361228 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Peripheral t-cell lymphoma | 19118030 | CNVD |
| Malignant melanoma | 17690212 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Acute promyelocytic leukemia | 19109227 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Neurodevelopmental disorder | 22521361 | CNVD |
| abortions and stillbirths | 19751515 | CNVD |
| Acute lymphoblastic leukemia | 21980252 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Prostate cancer | 16461572 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
| Burkitt''s lymphoma | 19759907 | CNVD |
| Malignant melanoma | 17260012 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Chronic myeloid leukemia | 21384125 | CNVD |
| Bladder cancer | 21909424 | CNVD |
| Biliary cancer | 19435499 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Splenic marginal zone lymphoma | 21957467 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Primary central nervous system lymphoma | 21088137 | CNVD |
| Liver carcinoma | 19366792 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Adenocarcinoma | 19607727 | CNVD |
| Multiple myeloma | 16461302 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Emphysema | 19352772 | CNVD |
| Effusion lymphoma | 18079361 | CNVD |
| Medulloblastoma | 17653508 | CNVD |
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
| Autism | 19401682 | CNVD |
| Neuroticism | 17667963 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Cancer | 19907438 | CNVD |
| Breast cancer | 21364760 | CNVD |
| abnormal development | 18461090 | CNVD |
| Cancer | 20164919 | CNVD |
| Breast cancer | 22522925 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Prostate cancer | 21147910 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr7:103298200-103305000 | Enhancers | HepG2 | liver |
| 2 | chr7:103300600-103303200 | Enhancers | Hela-S3 | cervix |
| 3 | chr7:103300800-103302000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
| 4 | chr7:103300800-103302000 | Enhancers | A549 | lung |
| 5 | chr7:103300800-103302000 | Enhancers | HMEC | breast |
| 6 | chr7:103300800-103302000 | Genic enhancers | K562 | blood |
| 7 | chr7:103301000-103302000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
| 8 | chr7:103301400-103302000 | Enhancers | Placenta | Placenta |
| 9 | chr7:103302000-103302400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
| 10 | chr7:103302000-103303000 | Weak transcription | K562 | blood |
| 11 | chr7:103302400-103303000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
| 12 | chr7:103303000-103304400 | Enhancers | K562 | blood |
| 13 | chr7:103303200-103306600 | Weak transcription | Hela-S3 | cervix |
| 14 | chr7:103305000-103313400 | Weak transcription | HepG2 | liver |
| 15 | chr7:103306600-103307800 | Enhancers | Hela-S3 | cervix |
| 16 | chr7:103308800-103309800 | Enhancers | Pancreatic Islets | Pancreatic Islet |






